BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rampton DS, Goodhand JR, Joshi NM, Karim AB, Koodun Y, Barakat FM, Macken L, Ward DG, Iqbal TH, Epstein J, Fell JM, Sanderson IR. Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial. J Crohns Colitis 2017;11:706-15. [PMID: 27932449 DOI: 10.1093/ecco-jcc/jjw208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Busti F, Marchi G, Girelli D. Iron replacement in inflammatory bowel diseases: an evolving scenario. Intern Emerg Med 2019;14:349-51. [PMID: 30721398 DOI: 10.1007/s11739-019-02043-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Scarallo L, Lionetti P. Dietary Management in Pediatric Patients with Crohn's Disease. Nutrients 2021;13:1611. [PMID: 34064976 DOI: 10.3390/nu13051611] [Reference Citation Analysis]
3 Gordon M, Sinopoulou V, Iheozor-Ejiofor Z, Iqbal T, Allen P, Hoque S, Engineer J, Akobeng AK. Interventions for treating iron deficiency anaemia in inflammatory bowel disease. Cochrane Database Syst Rev 2021;1:CD013529. [PMID: 33471939 DOI: 10.1002/14651858.CD013529.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Eriksson C, Henriksson I, Brus O, Zhulina Y, Nyhlin N, Tysk C, Montgomery S, Halfvarson J. Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study. Aliment Pharmacol Ther. 2018;48:638-645. [PMID: 30069892 DOI: 10.1111/apt.14920] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
5 Gargallo-Puyuelo CJ, Alfambra E, García-Erce JA, Gomollon F. Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a Paradigm. Nutrients 2018;10:E1959. [PMID: 30544934 DOI: 10.3390/nu10121959] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
6 Kennedy NA, Goodhand JR, Rampton DS. Editorial: which iron preparation for patients with IBD? Aliment Pharmacol Ther 2017;46:194-5. [PMID: 28621066 DOI: 10.1111/apt.14105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J. Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact. World J Gastroenterol 2021; 27(17): 2039-2053 [PMID: 34007138 DOI: 10.3748/wjg.v27.i17.2039] [Reference Citation Analysis]
8 Aksan A, Işık H, Radeke HH, Dignass A, Stein J. Editorial: which iron preparation for patients with IBD? Authors' reply. Aliment Pharmacol Ther 2017;46:195-6. [PMID: 28621074 DOI: 10.1111/apt.14126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]